Condition: Diabetic Ulcers · Arterial Ulcers · Venous Ulcers · Sponsor: Lohmann & Rauscher
The aim of this post market clinical follow up (PMCF) study is to confirm the performance of Debrisoft® Duo, to collect safety data regarding expected adverse events and to detect potential unexpected adverse events associated with the use of Debrisoft® Duo within the certified indications and under the conditions of routine use.
This description comes directly from the study's public registry record.
Claudia Feldkamp · +49 2631 99 7910 · claudia.feldkamp@de.lrmed.com
Always discuss trial participation with your own doctor first.
| MelissaMed Poradnia | Lodz, Poland | Recruiting |
| MIKOMED Sp. z.o.o. | Lodz, Poland | Recruiting |
| NZOZ Neuromed M. i M. Nastaj | Lublin, Poland | Recruiting |
| Specjalistyczny Osrodek Leczniczo Badawczy | Ostróda, Poland | Recruiting |
| Lecran - Centrum Opieki Nad Ranami-Kunickiego | Wroclaw, Poland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07312513